New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Advice on military veterans with concerns over Mefloquine (21 Sep 2016)

Individuals who may have taken Mefloquine prescribed by the Ministry of Defence (MoD) are now being offered support from the MoD’s Single Point of Contact (SPOC) for Mefloquine, launched on...
Read more »

Capita / PCSE delays in performers list applications (21 Sep 2016)

There have been delays in processing GP trainee applications for the Performers List beyond the three month window for applications to be processed. Whatever the reason, GP trainees are not...
Read more »

London GPs amongst most influential in the UK (21 Sep 2016)

Pulse magazine’s annual list of the 50 most influential GPs in the UK was published at the start of September. In its seventh year, the Power 50 recognised Dr Michelle...
Read more »

Sustainability and Transformation Plans - September 2016 Update (21 Sep 2016)

Sustainability and Transformation Plans in London On Wednesday 14 September MPs debated concerns regarding the impact of NHS Sustainability and Transformation Plans on frontline services. Challenging both the transparency and...
Read more »

Patient engagement survey shows patients are behind us (21 Sep 2016)

Our patient engagement survey reached both practice leads and members of patient participation groups (PPGs). Responses suggest that many of the current challenges faced by general practice are on the...
Read more »

Winter planning - start encouraging flu vaccinations now (19 Sep 2016)

Practices should have received their stocks of influenza vaccine by now. We strongly advise that practices who have yet to do so, to start informing their patients who are over 65...
Read more »

Speakers' Corner - Cancer awareness at The Royal Marsden (14 Sep 2016)

This month's Speakers' Corner comes from The Royal Marsden, the world renowned hospital that specialises in cancer care, treatment, research, training and education. This month is Gynaecological Cancer Awareness month. ...
Read more »

Mword - Issue 30 (12 Sep 2016)

12 September 2016...
Read more »
Next Page »
« Previous Page